Significant Deregulated Pathways in Diabetes Type II Complications Identified through Expression Based Network Biology
Type 2 Diabetes is a complex multifactorial disease, which alters several signaling cascades giving rise to serious complications. It is one of the major risk factors for cardiovascular diseases. The present research work describes an integrated functional network biology approach to identify pathways that get transcriptionally altered and lead to complex complications thereby amplifying the phenotypic effect of the impaired disease state. We have identified two sub-network modules, which could be activated under abnormal circumstances in diabetes. Present work describes key proteins such as P85A and SRC serving as important nodes to mediate alternate signaling routes during diseased condition. P85A has been shown to be an important link between stress responsive MAPK and CVD markers involved in fibrosis. MAPK8 has been shown to interact with P85A and further activate CTGF through VEGF signaling. We have traced a novel and unique route correlating inflammation and fibrosis by considering P85A as a key mediator of signals. The next sub-network module shows SRC as a junction for various signaling processes, which results in interaction between NF-kB and beta catenin to cause cell death. The powerful interaction between these important genes in response to transcriptionally altered lipid metabolism and impaired inflammatory response via SRC causes apoptosis of cells. The crosstalk between inflammation, lipid homeostasis and stress, and their serious effects downstream have been explained in the present analyses.
KeywordsDiabetes Type Cluster Coefficient Random Network Coexpression Network Closeness Centrality
Unable to display preview. Download preview PDF.
- 3.Kyriakis, J.M., Avruch, J.: Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 18(7), 567–557 (1996)Google Scholar
- 4.Dunand-Sauthier, I., Walker, C.A., Narasimhan, J., Pearce, A.K., Wek, R.C., Humphrey, T.C.: Stress-activated protein kinase pathway functions to support protein synthesis and translational adaptation in response to environmental stress in fission yeast. Eukaryot Cell 4(11), 1785–1793 (2005)CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Mauvais-Jarvis, F., Ueki, K., Fruman, D.A., Hirshman, M.F., Sakamoto, K., Goodyear, L.J., Iannacone, M., Accili, D., Cantley, L.C., Kahn, C.R.: Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Invest. 109(1), 141–149 (2002)CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Jelkmann, W.: Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin. Chem. 47(4), 617–623 (2001)Google Scholar
- 9.Suzuma, K., Naruse, K., Suzuma, I., Takahara, N., Ueki, K., Aiello, L.P., King, G.L.: Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J. Biol. Chem. 275(52), 40725–40731 (2000)CrossRefPubMedGoogle Scholar
- 11.Loukinova, E., Ranganathan, S., Kuznetsov, S., Gorlatova, N., Migliorini, M.M., Loukinov, D., Ulery, P.G., Mikhailenko, I., Lawrence, D.A., Strickland, D.K.: Platelet-derived Growth Factor (PDGF)-induced Tyrosine Phosphorylation of the Low Density Lipoprotein Receptor-related Protein (LRP). J. Biol. Chem. 277(18), 15499–15506 (2002)CrossRefPubMedGoogle Scholar
- 13.Wenzel, J., Sanzenbacher, R., Ghadimi, M., Lewitzky, M., Zhou, Q., Kaplan, D.R., Kabelitz, D., Feller, S.M., Janssen, O.: Multiple interactions of the cytosolic polyproline region of the CD95 ligand: hints for the reverse signal transduction capacity of a death factor. FEBS Lett. 509(2), 255–262 (2001)CrossRefPubMedGoogle Scholar
- 18.Häcker, H., Karin, M.: Regulation and function of IKK and IKK-related kinases. Sci. STKE. 357: re13 (2006)Google Scholar
- 20.Chen, X., Shevtsov, S.P., Hsich, E., Cui, L., Haq, S., Aronovitz, M., Kerkelä, R., Molkentin, J.D., Liao, R., Salomon, R.N., Patten, R., Force, T.: The beta-Catenin/T-Cell Factor/Lymphocyte Enhancer Factor Signaling Pathway Is Required for Normal and Stress-Induced Cardiac Hypertrophy. Mol. Cell. Biol. 26(12), 4462–4473 (2006)CrossRefPubMedPubMedCentralGoogle Scholar